Skip to content

    UPL Limited

    UPL
    Chemicals·1 Aug 2025
    Management Summary

    UPL reported a robust Q1 FY26 with 2% revenue growth and 14% EBITDA growth, driven by strong margin expansion and improved operational efficiency. The company significantly reduced net debt and improved working capital, despite facing macroeconomic headwinds in Latin America and pricing pressure from China oversupply. India Crop Protection and Seeds platforms showed strong double-digit growth, while the global crop protection business saw a slight decline.

    Highlights

    5
    • Revenue of ₹9,216 crores, up 2% YoY, driven by 1% price increase and favorable exchange impact.

    • EBITDA of ₹1,303 crores, up 14% YoY, with EBITDA margin improving 150 bps to over 14%.

    • Contribution margin expanded by 390 bps to over 43%, driven by improved product mix, favorable pricing, higher capacity utilization, and lower input costs.

    • Net debt reduced by ₹6,129 crores ($806 million) YoY to ₹21,371 crores ($2,492 million), and Net Debt to EBITDA improved from 5.4x to 2.6x.

    • Net working capital reduced by ₹3,300 crores YoY, with working capital days improving from 121 to 86 days.

    Concerns

    5
    • Q1 presented a challenging macroeconomic landscape, particularly across Brazil and broader Latin American markets, with lower commodity prices and higher interest rates.

    • UPL Corp (Global Crop Protection) revenue declined by 3% YoY, mainly due to seasonality-related challenges in Brazil (insecticide volume) and product phasing.

    • An ECL accrual of $13 million (₹112 crores) was made due to a distributor restructuring in Brazil, though it is non-cash and expected to unwind.

    • Net exchange losses increased from ₹143 crores to ₹178 crores, mainly from higher cost of hedging in Brazil due to increased local interest rates.

    • Advanta's GP to EBITDA clip was relatively narrow due to increased raw seed procurement costs, lower recovery rates from raw corn, and higher overheads from recruitment.

    What Changed2

    vs Q2 FY26

    Guidance items6 → 7 (+1)Risks discussed6 → 5 (-1)

    Key financials

    Single quarter

    08 metrics
    1. 01Revenue₹9,216 Cr+2%YoY
    2. 02Contribution₹4,001 Cr+12%YoY
    3. 03Contribution Margin43.4%
    4. 04EBITDA₹1,303 Cr+14.0%YoY
    5. 05EBITDA Margin14.1%

    Segment breakdown

    Revenue GrowthEBITDA Growth
    UPL SAS (India Crop Protection)13%
    Advanta (Seeds)5%
    SUPERFORM (Specialty Chemicals)9%7.0%
    UPL Corp (Global Crop Protection)-3%23%
    Heatmap· 2 shared metrics

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Debt

    Net ₹21,371 crores · 2.6x EBITDA

    Liquidity

    Liquidity disclosed

    Strong liquidity generation in Q4 FY25 used for debt prepayment. Fitch and S&P upgraded outlook from 'Negative' to 'Stable'.

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Revenue Growth
    4% to 8%
    High
    Revenue
    New Revenue from Product Launches
    $130 million
    High
    Profitability
    EBITDA Growth
    10% to 14%
    High
    ESG
    Reduction in Water Consumption, Carbon Dioxide, Waste Generation
    60%
    High
    Debt
    Gearing Ratios
    lower than last year
    High
    Debt
    Deleveraging
    significantly deleverage
    Medium
    Tax
    Effective Tax Rate
    15% to 17%
    High

    Advanta's GP to EBITDA clip improvement

    next quarter
    CurrentRelatively narrow in Q1 FY26
    TargetSignificant improvement in Q2 FY26

    Why it matters

    Indicates better operational efficiency and cost management in the seeds business, crucial for overall profitability.

    Going forward, I think things are likely to improve significantly in Q2.

    How to verify

    key_financials.segment_breakdown[name='Advanta (Seeds)'].metrics[label='EBITDA Growth']

    Risks & concerns

    5
    RiskSeverity

    Challenging macroeconomic landscape in Brazil and Latin America

    Lower commodity prices, farm income stress, higher interest rates, and volatile currencies impacting distributor performance.Management acknowledged

    medium

    Geopolitical uncertainties and US tariffs

    Ongoing geopolitical uncertainties and concerns around US tariffs continue to influence market sentiments and trade flows.Management acknowledged

    medium

    China oversupply and pricing pressure

    China oversupply related AI pricing pressure continues to exacerbate the overall business climate, particularly in the insecticide segment.Management acknowledged

    medium

    Brazil distributor restructuring and ECL accrual

    $13 million ECL accrual due to a distributor restructuring, which is non-cash and expected to unwind over the recovery period.Management acknowledged

    low

    Litigation impacting Advanta's M&A opportunities

    Significant litigation ongoing between Advanta and another company restricts exploring specific M&A opportunities like Nuseed until finalized.Management acknowledged

    medium

    Q&A highlights

    8

    “Advanta, very similar to our parent UPL, continues to explore inorganic options as part of our core strategy. You are very much aware about it. Hence, we diligently scout for assets that are a great fit for our portfolio as a routine part of our business. Now that you mention it, Nuseed is an interesting asset, given its geographic spread and portfolio offering. Moreover, it also fits well with Advanta in terms of revenue and cost synergies. However, there is significant litigation ongoing between two companies, which centers around the enforcement of the license agreement and some critical intellectual property. Advanta remains committed to protecting its IP and commercial rights and are pursuing all necessary legal avenues to protect its assets. The matter is ultimately set for trial, scheduled for next year in the Federal Court of Australia. Lastly, since the matter is currently sub judice, we are restricted in terms of sharing our further information in this regard. What we can confirm is that we are unable to explore this specific opportunity until the litigation is finalized.”

    Analyst inquired about Advanta's growth strategy and specific rumors regarding Nufarm's Nuseed business, which management confirmed as an interesting asset but currently unpursuable due to ongoing litigation, providing new information on a potential strategic move and its current roadblock.

    asked by Saurabh Jain

    2 min read5 chapters

    Detailed Narrative

    01

    Q1 FY26 Performance Overview and Macroeconomic Context

    UPL reported a robust Q1 FY26 with revenue growing 2% year-on-year to ₹9,216 crores, supported by a 1% price increase and favorable exchange rates. EBITDA saw a 14% increase to ₹1,303 crores, with the margin expanding by 150 basis points to over 14%. This performance was achieved despite a challenging macroeconomic landscape, particularly in Brazil and Latin America, marked by lower commodity prices, higher interest rates, and volatile currencies. China's oversupply also continued to exert pricing pressure on the overall business climate.

    02

    Liquidity Management and Ratings Upgrade

    The company demonstrated strong liquidity management by pre-paying a $250 million long-term loan due in September 2025 and redeeming $400 million in perpetual bonds in May 2025. The Rights Issue Committee also approved a second and final call of ₹1,688 crores ($200 million) from partly paid equity shares, with proceeds expected by the end of September. These actions, coupled with improved financial resilience, led to Fitch and S&P upgrading UPL's outlook from 'Negative' to 'Stable', reflecting confidence in its financial discipline.

    03

    Segmental Performance Highlights

    UPL's India Crop Protection business (UPL SAS) delivered strong growth, with revenue up 13% year-on-year, driven by a 9% volume increase and 4% improved pricing. Advanta, the seeds platform, achieved double-digit revenue growth, fueled by a 12% volume expansion, contributing to a 5% increase in EBITDA. The newly rebranded specialty chemicals platform, SUPERFORM, grew 9% led by volume, with its Super Specialty Chemicals (SSC) segment rising 21% year-on-year and EBITDA up 7%. In contrast, the global crop protection business (UPL Corp) saw a 3% revenue decline, primarily due to seasonal challenges and product phasing📎 in Brazil's insecticide segment.

    04

    Debt Reduction and Capital Efficiency

    UPL significantly reduced its net debt by ₹6,129 crores ($806 million) year-on-year, bringing the total to ₹21,371 crores ($2,492 million) as of June 2025. This led to a substantial improvement in the net debt-to-EBITDA ratio from 5.4x last year to 2.6x. Net working capital also improved by ₹3,300 crores, reducing working capital days from 121 to 86. The company's focus on operational efficiency and prudent financial management contributed to lower net finance costs, which decreased by 17% year-on-year to $74 million (₹631 crores), excluding exchange losses.

    05

    Outlook and Strategic Initiatives

    UPL remains confident in its FY26 guidance of 4-8% revenue growth and 10-14% EBITDA growth, with growth expected to be weighted towards the second half⚖️ of the year. The company is committed to delivering $130 million in new revenue from product launches this year, mostly in H2. Strategically, UPL is evaluating various options to further deleverage its balance sheet over the next one to two years and unlock value across its platforms. The company also reiterated its commitment to ESG, targeting a 60% reduction in water consumption, carbon dioxide, and waste generation by FY30.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.